NPSR1 promotes chronic colitis through regulating CD4+ T cell effector function in inflammatory bowel disease
Year: 2024
Type: article
Abstract: • NPSR1 playing a pro-inflammatory role in IBD. • NPSR1 promotes the proliferation and differentiation into subsets of CD4 + T cells. • NPSR1 inhibits CCL2-induced migration of CD4 + T cells in vitro. • NPSR1 promotes Th1 cell chemotaxis in vivo . Neuropeptide S receptor 1 (NPSR1) has been implicated in the the onset of inflammatory bowel disease (IBD), though its exact mechanism remains unclear. This study investigates the role of NPSR1 in regulating CD4 + T cell effector function in IBD. Peripheral blood and colonic mucosal biopsies from IBD patients, as well as dextran sodium sulfate (DSS)-induced mouse colitis models, were analyzed to assess the effects of NPSR1 on colitis and CD4 + T cell-mediated immune responses. NPSR1 knockdown was conducted both in vitro and in vivo to elucidate underlying mechanisms. Expression of NPSR1 and CD4 + T cell-related factors was measured using quantitative real-time PCR, immunoblotting, cytometric bead array, immunofluorescence, and immunohistochemistry. CD4 + T cell effector functions were evaluated through flow cytometry, EdU incorporation assay, Annexin V-FITC/PI staining, and transwell assay. NPSR1 expression was elevated in the intestinal tissues from IBD patients. Its downregulation provided protection in DSS-induced mouse colitis models. NPSR1 correlated positively with CD4 + T cell-mediated inflammation, and its knockdown reduced CD4 + T cell-mediated immune responses and inhibited CD4 + T cell differentiation. Additionally, NPSR1 knockdown decreased CD4 + T cell proliferation, increased apoptosis, and enhanced CCL2-induced migration in vitro , while significantly reducing Th1 cell chemotaxis in vivo . This study demonstrates that NPSR1 promotes chronic colitis by regulating CD4 + T cell effector functions in IBD, offering potential new therapeutic strategies for IBD treatment.
Source: International Immunopharmacology
Authors: Yanan Peng, Liping Chen, Xiaojia Chen, Jun Lin, Jia Wei, Jie Cheng, Feng Zhou, Liuqing Ge, Rui Zhou, Feng Ding, Xiaobing Wang
Language: English
Topic: Inflammatory Bowel Disease
Subfield: Genetics
Domain: Life Sciences
Open Access status: hybrid
Estimated APC paid: $3,250
Awards: G1270642926, G6729767330
OpenAlex ID: W4402878678
